PE-22-28 10mg | Neuroregulatory Research Peptide – Grail Formula Quality
For research use only – not for human or veterinary administration.
Product Overview
PE-22-28 is a synthetic research peptide developed for controlled laboratory investigation into neuroregulatory signalling pathways and receptor interaction dynamics. Formulated as a 10mg lyophilized powder and supplied in a hermetically sealed research vial, this preparation is engineered to deliver the consistency and reliability critical for reproducible in vitro biochemical experimentation.
Peptide Profile
PE-22-28 is a key tool in laboratory models exploring peptide-mediated neuronal communication and the modulation of cellular regulatory pathways. Its well-characterized molecular structure and robust stability profile make it an ideal candidate for comparative neuropeptide analysis—all under the tightly controlled conditions required for rigorous scientific research.
Scientific Background
Research into short-chain regulatory peptides has expanded dramatically since the late 20th and early 21st centuries, as global laboratories advance understanding of peptide-driven modulation of central cellular signalling systems. PE-22-28 is leveraged within this evolving research framework to study receptor-binding kinetics, intracellular cascade activation, and the modelling of neuroregulatory pathways at the molecular level.
Primary Research Focus Areas
Neuroregulatory receptor interaction analysis
Peptide-mediated signalling pathway modelling
Intracellular cascade activation characterization
Comparative neuropeptide structure–function evaluation
Controlled in vitro biochemical and cellular investigations
Analytical Verification & COA Details
Batch GF102025052 has undergone comprehensive independent analysis by Liquilabs s.r.o., with all testing conducted via validated chromatographic, spectroscopic, and microbiological methodologies. Analytical results for this batch confirm:
Assay Content: 9.93 mg
Retention Time Identification: 0.998
Spectral Identification: 999
Purity: ≥99.8%
Endotoxin: Detected at levels below 0.01 EU/mg
Total Aerobic Microbial Count: Not detected
Total Yeast & Mold Count: Not detected
Heavy Metals: None detected (arsenic, cadmium, cobalt, lead, nickel, mercury, vanadium)
All results are specific to the tested batch sample and generated in compliance with standard research peptide analytical protocols.
Key Research Applications
Mechanistic study of neuroregulatory pathways
Receptor-binding affinity and signalling cascade research
In vitro peptide-receptor interaction modelling
Comparative evaluation of neuropeptide activity
Controlled laboratory-based biochemical investigations
Grail Formula Quality Commitment
Every Grail Formula research peptide is subjected to rigorous independent third-party laboratory testing—verifying identity, assay accuracy, raw material purity, and microbial safety. Each production batch is validated for analytical consistency and experimental reproducibility, ensuring the high-quality standards needed to support reliable, publishable scientific research outcomes.
What You Get with Grail Formula
When you select Grail Formula research peptides, you receive fully documented materials with complete batch-number traceability and hermetically sealed vial integrity—engineered specifically for the demands of academic and industrial laboratory research.
Important Usage Restrictions
This peptide is manufactured solely for in vitro experimental use and is not authorized for:
Human clinical trial applications
Direct administration to humans in any experimental setting
Supply for human investigational research purposes